Prasandhya Astagiri Yusuf – Audioneurotechnology – Excellence in Innovation 

Posted on by ScienceFather

Assist Prof Dr. Prasandhya Astagiri Yusuf - Audioneurotechnology - Excellence in Innovation 

Faculty of Medicine, Universitas - Indonesia

Author Profile

Early Academic Pursuits

Assist Prof Dr. Prasandhya Astagiri Yusuf's academic journey commenced with a strong foundation in the sciences, evident from his Bachelor of Science degree in Physics from the prestigious Institut Teknologi Bandung, Indonesia. Following this, he pursued his Master of Engineering in Biomedical Engineering, specializing in Electrical Engineering, from the same institution. This interdisciplinary background laid the groundwork for his later contributions in the field of auditory science.

Professional Endeavors

With a passion for biomedical engineering and a keen interest in auditory sciences, Prasandhya embarked on a career path focused on research and academia. He began his professional journey in 2009, where he engaged in groundbreaking research and development projects at the Bandung Ear Care Foundation. Here, he played a pivotal role in designing and producing innovative audiometric devices catering to both adult and infant populations, showcasing his commitment to improving healthcare accessibility.

Parallelly, he commenced his academic career as a Lecturer and Researcher at Biomedical Technology, Interdisciplinary Postgraduate Program, Universitas Indonesia, where he contributed to shaping the minds of future engineers and scientists. His dedication to academia continued as he progressed to the role of Assistant Professor at the Medical Physiology and Biophysics Department, Faculty of Medicine, Universitas Indonesia.

Contributions and Research Focus

Assist Prof Dr. Prasandhya's research endeavors span a wide spectrum within the field of auditory science and biomedical engineering. His doctoral research, conducted at the prestigious Hannover Medical School in Germany, focused on higher-order auditory areas in congenital deafness, shedding light on top-down interactions and corticocortical decoupling. This seminal work paved the way for a deeper understanding of auditory processing mechanisms in individuals with hearing impairments.

Throughout his career, Prasandhya has been involved in numerous research projects, addressing critical healthcare challenges such as COVID-19 management, artificial kidney technology, and medical device innovation. His multidisciplinary approach, coupled with his expertise in machine learning and artificial intelligence, has led to impactful contributions in areas ranging from early disease detection to telemedicine applications.

Accolades and Recognition

Assist Prof Dr. Prasandhya's contributions to academia and research have been widely recognized, evident from his extensive publication record in reputable journals and conference proceedings. His research findings have not only contributed to the scientific community's knowledge but have also been instrumental in shaping healthcare policies and practices.

Furthermore, Prasandhya's dedication to teaching and mentorship has been acknowledged through his supervision of numerous Master's and Ph.D. theses, guiding aspiring researchers in their academic pursuits.

Impact and Influence

Assist Prof Dr. Prasandhya's work has had a profound impact on both academia and industry. His innovative solutions in medical device development and his insights into auditory processing have the potential to revolutionize healthcare delivery, particularly in underserved communities. By bridging the gap between research and practical applications, Prasandhya has positioned himself as a thought leader in the field, inspiring future generations of researchers and engineers.

Legacy and Future Contributions

As Prasandhya continues to chart new frontiers in biomedical engineering and auditory science, his legacy as a visionary researcher and educator is firmly established. With a steadfast commitment to advancing healthcare technologies and improving patient outcomes, he remains dedicated to pushing the boundaries of knowledge and innovation. His future contributions are poised to leave an indelible mark on the field, shaping the landscape of healthcare for years to come.

Notable Publication

 

Hermona Soreq – molecular neuroscience – Outstanding Scientist Award

Posted on by ScienceFather

Early Academic Pursuits

Prof. Hermona Soreq's academic journey began with a solid foundation in biochemistry and microbiology at The Hebrew University of Jerusalem, where she earned her Bachelor of Science in 1967. She further pursued her Master’s degree at Tel Aviv University, focusing on biochemistry and chemistry teaching, which she completed in 1970. Her academic rigor and passion for molecular studies led her to The Weizmann Institute of Science, where she obtained her PhD in Biochemistry in 1976. Soreq's early career was marked by a prestigious Fogarty Fellowship at Rockefeller University, allowing her to delve into molecular cell biology from 1977 to 1979.

Professional Endeavors

Prof. Hermona Soreq's professional career is distinguished by her long-term association with The Hebrew University of Jerusalem. She joined the faculty in 1986 as the Slesinger Chair of Molecular Neuroscience, a position she has held with distinction. Her roles have included serving as the elected Dean of the Faculty of Mathematics and Natural Sciences from 2005 to 2008, and she is a founding member of the Edmond and Lily Safra Center for Brain Sciences (ELSC). Additionally, Soreq has held prominent positions at the Weizmann Institute and Arizona State University’s Bio-Design Institute, reflecting her international influence and collaborative approach to scientific research.

Contributions and Research Focus

Prof. Hermona Soreq’s research primarily focuses on the complex role of non-coding RNA controllers, particularly microRNAs (miRs) and transfer RNA fragments (tRFs), in brain-to-body functioning. Her groundbreaking work on acetylcholine-related pathways has combined advanced computational neuroscience with cutting-edge technologies such as sequencing, transgenic engineering, and microscopy. This multidisciplinary approach has enabled significant discoveries, including the identification of "CholinomiR" silencers that regulate anxiety, inflammation, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Her research has also highlighted the impact of these non-coding RNAs on conditions like stroke, epilepsy, and metabolic disorders.

Accolades and Recognition

Prof. Hermona Soreq's contributions to molecular neuroscience have earned her numerous accolades and honors. She has received Honorary PhDs from prestigious institutions including the University of Stockholm, Ben-Gurion University, and Friedrich-Alexander University Erlangen-Nuremberg. Other notable awards include the Teva Founders’ Award, the Lise Meitner Alexander von Humboldt Award, and the Rappaport Prize for Biomedical Research. In 2022, she was awarded the Israeli Prime Minister’s EMET prize in Neuroscience, recognizing her exceptional contributions to the field. Soreq has also been a keynote speaker at major international conferences, further solidifying her status as a leading voice in neuroscience.

Impact and Influence

Throughout her career, Hermona Soreq has had a profound impact on the scientific community, both through her research and her mentorship. She has trained 26 faculty members who have gone on to contribute to various universities worldwide, including institutions in Jerusalem, Tel Aviv, Haifa, the Galilee, Beer Sheva, and internationally in Berkeley, Maryland, Halifax, Ann Arbor, Paris, Tours, Jena, and London. Her research on the cholinergic system’s involvement in stress, neurodegeneration, and metabolic regulation has opened new avenues for understanding and potentially treating these conditions.

Legacy and Future Contributions

Prof. Hermona Soreq’s legacy is characterized by her innovative approach to neuroscience, integrating computational and experimental methods to explore the regulatory roles of non-coding RNAs. Her work has not only advanced scientific knowledge but also has significant implications for therapeutic strategies in treating neurodegenerative and stress-related diseases. As she continues her research, Soreq is poised to make further groundbreaking discoveries that will influence the field for years to come. Her ongoing involvement in academic and scientific advisory boards, including those at Neuro-Cure Center Berlin and the ImmunoSensation Center Bonn, ensures that her expertise will continue to guide and inspire future generations of neuroscientists.

Citations

A total of 34743 citations for his publications, demonstrating the impact and recognition of her research within the academic community.

  • Citations  34743
  • h-index       98
  • i10-index    370

Notable Publication

 

Paolo Immovilli – Neurologia – Best Researcher Award 

Posted on by ScienceFather

Dr. Paolo Immovilli - Neurologia - Best Researcher Award 

University of Parma - Italy

Author Profile

Early Academic Pursuits

Dr. Paolo Immovilli's academic journey commenced with a solid foundation laid during his formative years in Pontedera, Italy. Born on March 1, 1974, he demonstrated early promise, which led him to pursue a scientific track in education. Graduating with distinction from high school with a score of 50/60, he embarked on his journey in the medical field by enrolling at the University of Parma's Faculty of Medicine and Surgery. His academic trajectory was marked by diligence and dedication, setting the stage for his future contributions to the field of neurology.

Professional Endeavors

Dr. Immovilli's professional journey mirrors a commitment to patient care and advancement in neurology. After earning his medical degree with honors, he delved into clinical practice, initially serving as a substitute physician in general medicine and tourist medical services. His tenure at various healthcare facilities provided him with diverse experiences, from primary care to specialized neurology services. Noteworthy is his stint at the Neurology Clinic in Parma, where he honed his skills in diagnosing and treating neurological disorders, with a particular focus on multiple sclerosis (MS).

Transitioning seamlessly from residency to a permanent role as a medical manager at the Neurology Unit of Guglielmo da Saliceto Hospital in Piacenza, Dr. Immovilli assumed increasing responsibilities. His leadership in the MS Center underscored his innovative approaches to treatment, including the introduction of novel therapies and off-label treatments for MS and neuromyelitis optica.

Contributions and Research Focus On Neurologia

Dr. Immovilli's research endeavors have significantly enriched the understanding of neurological conditions, particularly MS, stroke, headache disorders, and their intersection with COVID-19. His prolific publication record, comprising over 91 articles in national and international journals, attests to his scholarly contributions. Notably, his research has been instrumental in elucidating the genetic underpinnings of MS, exploring novel treatment modalities, and investigating the impact of COVID-19 on neurological outcomes.

As a principal or co-investigator in numerous clinical studies, Dr. Immovilli has demonstrated his expertise in study design, protocol development, and data analysis. His involvement in multicenter trials and collaborative projects underscores his commitment to advancing neurology through interdisciplinary collaboration.

Accolades and Recognition

Dr. Immovilli's scholarly achievements have garnered widespread recognition within the medical community. His impressive bibliometric indices, including an H-index of 20 and over 1500 citations, underscore the impact of his research contributions. Moreover, his leadership roles in regional advisory committees and his involvement in advisory boards for pharmaceutical companies highlight his stature as a trusted authority in neurology.

Impact and Influence

Dr. Immovilli's impact extends beyond academia, as evidenced by his pivotal role in shaping clinical practice guidelines and healthcare policies. His efforts to integrate research findings into clinical practice have translated into improved patient outcomes and enhanced quality of care for individuals with MS and other neurological disorders.

Legacy and Future Contributions

Dr. Immovilli's legacy lies in his unwavering dedication to advancing neurology through a multifaceted approach encompassing clinical care, research, and education. His pioneering work in MS and other neurological conditions has laid the groundwork for future breakthroughs in treatment and management strategies. As he continues to lead initiatives aimed at enhancing patient care and driving innovation in neurology, Dr. Immovilli remains a beacon of inspiration for aspiring neurologists and researchers alike.

Citations

  • Citations   2866
  • h-index       24
  • i10-index    37

Notable Publication

Electra Papadopoulou | Women Researcher Award | Emerging Research Trends

Posted on by ScienceFather

Electra Papadopoulou - Chimar Hellas Sa - Emerging Research Trends🏆

Dr Electra Papadopoulou : Emerging Research Trends

Professional profile:

Early Academic Pursuits:

 Dr. Electra Papadopoulou embarked on her academic journey with a Bachelor of Science in Chemistry from the School of Sciences at Aristotle University of Thessaloniki, Greece, in 2002. Her passion for learning continued as she pursued a Master of Science in Materials Science in 2010, also at Aristotle University. Notably, she expanded her academic horizons by earning an MPhil in bio-based materials from Aston University in the U.K. in 2009. This diverse educational background laid the foundation for her subsequent achievements.

Professional Endeavors:

Throughout her career,  Dr.Electra Papadopoulou has demonstrated her expertise and commitment in the field of research and development. Starting as an Officer in the Intellectual Property Protection & R&D Support Department at  Dr. in 2000, she progressively advanced to the role of Senior Researcher and Bioeconomy Expert in the R&D Department. Her journey with CHIMAR HELLAS S.A spans from 2000 to the present, showcasing her long-standing dedication to the organization.

Contributions and Research Focus:

Electra's research focus is underscored by her academic achievements, with a PhD in Physics obtained from the School of Sciences at Aristotle University of Thessaloniki in 2019. Currently serving as a Postdoctoral Researcher in the Physics School at the same university, she continues to contribute to the academic community. Her expertise extends to bio-based materials, aligning with her MPhil specialization, and her role as a key figure in the field of bioeconomy is evident through her leadership as the Co-Founder and President of the Greek Bioeconomy Forum.

Accolades and Recognition:

Electra Papadopoulou's commitment and expertise have not gone unnoticed. Her role as a Review Panel expert for COST Actions/EU from 2017 to 2023 and her membership in the EU Bioeconomy panel (DG R&D) from 2013 to 2015 exemplify the recognition she has received at the European level. Additionally, her involvement in the Advisory Group of the Greek Secretariat of Research and Innovation and the Strategic Partnership Planning Group of the Ministry of Rural Development and Food highlights her impact on national policy and development.

Impact and Influence:

As a Senior Researcher and Bioeconomy Expert, Electra has significantly contributed to CHIMAR HELLAS S.A's R&D Department, playing a pivotal role in shaping the organization's trajectory. Her influence extends beyond her workplace, as seen in her active participation in various national and European committees, showcasing her commitment to advancing research, innovation, and sustainable development.

Legacy and Future Contributions:

 Dr.Electra Papadopoulou has established herself as a leading figure in the intersection of physics, materials science, and bioeconomy. Her legacy is marked by her role in founding and presiding over the Greek Bioeconomy Forum, influencing policy decisions, and contributing to numerous seminars and courses. Moving forward, her dedication to research and sustainable development positions her as a key contributor to future advancements in the field. Her multifaceted expertise, from intellectual property protection to chemical hazard classification, exemplifies a versatile professional poised to make enduring contributions to science and innovation.

Notable Publication:

Electra Papadopoulou, Theresa Rücker, Zoe Nikolaidou, Sotirios Kountouras, Themistoklis Sevastiadis, Torbjørn Pettersen, Bernd Wittgens, Electrochemically treated lignin in phenolic resins for plywood panels, Sustainable Chemistry for the Environment, Volume 4, 20 December 2023, 100049, https://doi.org/10.1016/j.scenv.2023.100049

Lamprini Malletzidou, Electra Papadopoulou, Lazaros Papadopoulos, Charles Markessini, Dimitrios N. Bikiaris, Konstantinos Chrissafis, George Vourlias, Novel Biobased Polyester Resins for Wood Applications: Morphological, Thermal, and Chemical Characterization, Symp. 405, Issue 1, October 2022. https://doi.org/10.1002/masy.202100229

Sarmite Janceva, Anna Andersone, Uldis Spulle, Ramunas Tupciauskas, Electra Papadopoulou, Oskars   Bikovens, Martins Andzs, Natalija Zaharova, Gints Rieksts and Galina Telysheva, Eco-Friendly Adhesives Based on the Oligomeric Condensed Tannins-Rich Extract from Alder Bark for Particleboard and Plywood Production, Materials 2022, 15(11), 3894; https://doi.org/10.3390/ma15113894

Lazaros Papadopoulos, Lamprini Malletzidou, Dimitra Patsiaoura, Andreas Magaziotis, Eleni Psochia, Zoi Terzopoulou, Konstantinos Chrissafis, Charles Markessini, Electra Papadopoulou and Dimitrios N. Bikiaris, Synthesis and Characterization of Unsaturated Succinic Acid Biobased Polyester Resins, Sci. 2021, 11(3), 896; https://doi.org/10.3390/app11030896

Evangelia Tarani, Dimitra Patsiaoura, Electra Papadopoulou, Eleni Pavlidou and Konstantinos Chrissafis, A New Textile Economy: Synthesis and Characterization of Phenolic Type Resin with Protein from Waste Textiles Suitable for Wood-Based Panels, mpdi, Proceedings 2021, 69, 15. https://doi.org/10.3390/CGPM2020-07222